Business Context and Reporting Period
This Form 8-K Current Report was filed by iBio, Inc. on July 17, 2026. The filing serves to announce the date of the Company's 2026 Annual Meeting of Stockholders and to establish revised deadlines for the submission of stockholder proposals and director nominations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing regarding corporate governance and does not contain financial performance data.
Material Changes
There are no material financial changes reported. The primary change is the scheduling of the 2026 Annual Meeting for October 14, 2026, which is more than 30 days prior to the anniversary of the 2025 Annual Meeting. Consequently, standard deadlines for stockholder proposals under Rule 14a-8 and the Company's Bylaws have been adjusted.
Guidance, Outlook, and Corporate Governance
- Annual Meeting Date: October 14, 2026.
- Record Date: September 1, 2026 (close of business).
- Rule 14a-8 Proposal Deadline: Stockholder proposals for inclusion in the proxy statement must be received by August 1, 2026.
- Bylaw Proposal Deadline: Proposals intended to be presented at the meeting but not included in the proxy materials must be received by July 27, 2026.
- Universal Proxy Deadline: Notice for director nominees other than the Company's nominees must be provided by August 15, 2026.
Key Facts for Investor Verification
- Verify the definitive proxy statement for the exact time and location of the 2026 Annual Meeting.
- Confirm the August 1, 2026 deadline for Rule 14a-8 proposals to ensure timely inclusion in proxy materials.
- Note the July 27, 2026 deadline for stockholder proposals under the Company's Bylaws if not seeking inclusion in the proxy statement.
- Review the August 15, 2026 deadline for universal proxy rule compliance regarding director nominations.